Brolucizumab: is extended VEGF suppression on the horizon?

Ashish Sharma; Nilesh Kumar; Baruch D. Kuppermann; Anat Loewenstein; Francesco Bandello

doi:10.1038/s41433-019-0582-0

Brolucizumab: is extended VEGF suppression on the horizon?

Ashish Sharma, Nilesh Kumar, Baruch D. Kuppermann, Anat Loewenstein, Francesco Bandello

Clinical Departments

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	424-426
Number of pages	3
Journal	Eye
Volume	34
Issue number	3
DOIs	https://doi.org/10.1038/s41433-019-0582-0
State	Published - 1 Mar 2020

Access to Document

10.1038/s41433-019-0582-0

Cite this

@article{1550246ecb95425aa83a43f8a6b7d503,

title = "Brolucizumab: is extended VEGF suppression on the horizon?",

author = "Ashish Sharma and Nilesh Kumar and Kuppermann, {Baruch D.} and Anat Loewenstein and Francesco Bandello",

year = "2020",

month = mar,

day = "1",

doi = "10.1038/s41433-019-0582-0",

language = "אנגלית",

volume = "34",

pages = "424--426",

journal = "Eye",

issn = "0950-222X",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - Brolucizumab

T2 - is extended VEGF suppression on the horizon?

AU - Sharma, Ashish

AU - Kumar, Nilesh

AU - Kuppermann, Baruch D.

AU - Loewenstein, Anat

AU - Bandello, Francesco

PY - 2020/3/1

Y1 - 2020/3/1

UR - http://www.scopus.com/inward/record.url?scp=85073814672&partnerID=8YFLogxK

U2 - 10.1038/s41433-019-0582-0

DO - 10.1038/s41433-019-0582-0

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 31527765

AN - SCOPUS:85073814672

VL - 34

SP - 424

EP - 426

JO - Eye

JF - Eye

SN - 0950-222X

IS - 3

ER -

Brolucizumab: is extended VEGF suppression on the horizon?

Access to Document

Other files and links

Cite this